Interaction Between <i>PPARA</i> Genotype and β-Blocker Treatment Influences Clinical Outcomes Following Acute Coronary SyndromesSharon Cresci, John A. Spertus, David E. Lanfear et al.|Pharmacogenomics|2008Cited by 19
Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic CardiomyopathyCarmen C. Sucharov, Shelley D. Miyamoto|Circulation Heart Failure|2023Cited by 11
Interaction between PPARA genotype and β-blocker treatment influences clinical outcomes following acute coronary syndromesPhilip G. Jones, Adam Garsa, Michael Courtois et al.|Unknown|2021Cited by 0